img logo ins

By means of simple letter to the General Director of the Research and Technological Transfer General Office (OGITT) of the National Health Institute_

  • Notification for Early Termination of Clinical Trial.
  • Notification for Transfer or Delegation of responsibilities in authorized clinical trials (within the framework of Article 41° of the Clinical Trials Regulation in Peru).
  • Research Product Safety Reports (except Reas-Net).
  • Reference for Investigator’s Brochure updates.
  • Other notifications